Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novo Integrated Sciences Inc (NVOS)

Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 967
  • Shares Outstanding, K 19,730
  • Annual Sales, $ 12,570 K
  • Annual Income, $ -13,210 K
  • EBIT $ -10 M
  • EBITDA $ -3 M
  • 60-Month Beta -1.62
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book 0.08
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.18
  • Most Recent Earnings $-0.74 on 07/19/24
  • Next Earnings Date 12/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0270 +81.48%
on 11/08/24
0.2409 -79.66%
on 10/22/24
-0.1781 (-78.42%)
since 10/18/24
3-Month
0.0270 +81.48%
on 11/08/24
0.4300 -88.60%
on 08/19/24
-0.3270 (-86.97%)
since 08/16/24
52-Week
0.0270 +81.48%
on 11/08/24
1.6150 -96.97%
on 11/20/23
-1.4910 (-96.82%)
since 11/17/23

Most Recent Stories

More News
Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the issuance of an unsecured 15-year $70,000,000 promissory note with RC Consulting LLC in favor of SCP...

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple...

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences Provides Update on Certain Current Actions and Events

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to certain actions and events, as follows:

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today reported that it received a notice on January 25, 2023 from the Listing Qualifications Department of The Nasdaq Stock...

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences Provides Update on Certain Current Actions and Events

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to certain actions and events, as follows:

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today reported that it received a notice (the “Notice) on December 15, 2022 from the Listing Qualifications Department...

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International LLC (“CCI”), a Novo wholly-owned subsidiary, today announced the signing of a...

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International (“CCI”), a Novo wholly-owned subsidiary, today announced the signing of a Sales...

NVOS : 0.0490 (+35.73%)
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International (‘CCI’), a Novo wholly-owned subsidiary, today announced the signing of a Sales...

NVOS : 0.0490 (+35.73%)
Pre-Market Brief: Stocks Mixed After Indices Stage Sharp Reversal

December S&P 500 futures (ESZ22) are trending down -0.20% this morning after three major US benchmark indices made a dramatic recovery, closing sharply higher after an earlier sell-off on Thursday as the...

ESZ22 : 3,871.47s (-0.66%)
IMRA : 6.32 (+15.96%)
EAR : 2.57 (-4.10%)
NVOS : 0.0490 (+35.73%)
RETA : 172.36 (+0.02%)
RLMD : 3.02 (+0.33%)

Business Summary

Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.0692
2nd Resistance Point 0.0595
1st Resistance Point 0.0543
Last Price 0.0490
1st Support Level 0.0394
2nd Support Level 0.0297
3rd Support Level 0.0245

See More

52-Week High 1.6150
Fibonacci 61.8% 1.0084
Fibonacci 50% 0.8210
Fibonacci 38.2% 0.6336
Last Price 0.0490
52-Week Low 0.0270

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar